Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.

Pancreas - 1 Jul 2012

Schultz Nicolai Aagaard, Roslind Anne, Christensen Ib J, Horn Thomas, Høgdall Estrid, Pedersen Lisbeth N, Kruhøffer Mogens, Burcharth Flemming, Wøjdemann Morten, Johansen Julia S

Abstract excerpt

OBJECTIVES: The frequencies and prognostic role of KRAS and BRAF mutations in patients operated on for pancreatic ductal adenocarcinomas (PDACs) and ampullary adenocarcinomas (A-ACs) are scantily studied. METHODS: KRAS and BRAF mutations were analyzed in formalin-fixed, paraffin-embedded tumor sa...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Smoking

Source

Identifiers

PMID: 22699145
DOI: 10.1097/MPA.0b013e31823cd9df

Genes

KRAS
BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22699145-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.PMID 22699145Read ↗

Survival in ampullary cancer: potential role of different KRAS mutations.Semantic proximity Read ↗

Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Prognostic Properties of KRAS Gene Mutation Subtypes in Resected Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic Cancer.Semantic proximity Read ↗

KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review.Semantic proximity Read ↗

EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer.Semantic proximity Read ↗

Prognostic Implications of Codon-Specific<i>KRAS</i>Mutations in Localized and Advanced Stages of Pancreatic CancerSemantic proximity Read ↗

KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation?Semantic proximity Read ↗

Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.Semantic proximity Read ↗

Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Semantic proximity Read ↗

Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma.Semantic proximity Read ↗

Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient SurvivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.